通过皮肤蓝光辐射免疫激活抑制远程瘤生长和转移
Yingchun Yang1, Rong Yang1, Fangqing Deng1
1Key Laboratory for Space Bioscience & Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an 710072, China.
ACS pharmacology & translational science
|April 18, 2024
概括
蓝光疗法通过调节活性氧物种 (ROS) 来非侵入性地增强先天免疫力. 这种免疫激活抑制瘤生长和转移,提供了一种新的临床方法.
科学领域:
- 免疫学 免疫学 免疫学
- 生物物理学的生物物理.
- 皮肤病学 皮肤病学
背景情况:
- 有效的先天免疫对于病原体反应和适应性免疫是至关重要的.
- 目前用于快速增强先天免疫力的临床方法有限.
- 免疫调节的非侵入性策略非常受欢迎.
研究的目的:
- 为了研究蓝光照射对快速,非侵入性先天免疫刺激的潜力.
- 阐明蓝光诱导免疫激活的潜在分子机制.
- 评估蓝光在抑制瘤进展方面的治疗效果.
主要方法:
- 在临床前模型中利用450nm蓝光进行皮肤照射.
- 测量了活性氧物种 (ROS) 生产和信号通路激活 (NF-κB).
- 评估免疫细胞透 (中性粒细胞,巨细胞) 和瘤生长/转移.
主要成果:
- 蓝光通过内源ROS调节迅速刺激先天免疫力.
- 铁氨酸蛋白质 (细胞染色体c,细胞染色体P450) 的调动促进了ROS的产生.
- 激活的NF-κB信号传递和细胞因子分泌导致了系统性免疫激活.
- 全身蓝光照射通过增强抗瘤免疫细胞透来抑制瘤生长和转移.
结论:
- 蓝光照射提供了一种非侵入性方法,可以快速激活先天免疫力.
- 该机制涉及ROS调节,NF-κB激活和细胞因子介导的全身效应.
- 这种方法为癌症免疫疗法和免疫增强提供了一个有前途的临床策略.
更多相关视频
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.7K
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.3K
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
